Cleopatra Hospitals Group has invested greater than EGP 1bn in high quality, infrastructure, and medical know-how growth since 2015.
The corporate famous that it had not distributed annual dividends, with 100% of the retained earnings reinvested within the group’s enterprise.
It added that the proposed alliance with the Alameda Healthcare Group will result in a rise within the funding potential of the healthcare sector. On the identical time, it is going to present higher entry to low-cost capital that might be directed in direction of the governorates that endure from a scarcity of hospital capability.
Cleopatra Hospitals added that its market share has grown inside 5 years, to about 8% of the capability of the business beds within the Higher Cairo. It’s anticipated that the allied group’s share will attain 15% after the deal’s completion, guaranteeing the supply of an estimated 14,000 business beds.
The Competitors Safety Authority (CPA) had issued a preliminary determination towards the Cleopatra Hospitals Group’s acquisition of the Alameda Healthcare Group. The CPA based mostly its determination on indications that the deal would have a unfavorable influence on Egypt’s healthcare sector.
The CPA added that it’s eager to forestall monopolistic actions in Egypt’s healthcare market, and the hurt which will comply with whether or not within the provision of healthcare or value hikes.
The UAE firm Alameda owns and operates plenty of hospitals and medical centres in Egypt by its subsidiaries, together with the Al-Salam Worldwide Hospital in Maadi, Dar Al-Fouad in sixth of October, Dar Al-Fouad in Nasr Metropolis, and Al-Salam Worldwide Hospital in Katameya.